Literature DB >> 25059855

"Ballooning" patterns in takotsubo cardiomyopathy reflect different clinical backgrounds and outcomes: a BOREAS-TCM study.

Junichi Nishida1, Hidemichi Kouzu1, Akiyoshi Hashimoto1, Takefumi Fujito1, Mina Kawamukai1, Atsushi Mochizuki1, Atsuko Muranaka1, Nobuaki Kokubu1, Shinya Shimoshige1, Satoshi Yuda2, Mamoru Hase3, Kazufumi Tsuchihashi4, Tetsuji Miura5.   

Abstract

Whether different patterns of ventricular ballooning in takotsubo cardiomyopathy (TCM) reflect differences in trigger mechanisms or clinical outcomes is unclear. Here we examined differences in the clinical characteristics of typical and atypical forms of TCM. TCM patients (n = 251) in the BOREAS Registry were enrolled for comparison of TCM with apical ballooning (type A, n = 217) and TCM with non-apical ballooning (type non-A, n = 34). The percentage of females was significantly lower in the type non-A group (58.8 vs. 75.6 %), while other demographic parameters and triggers of TCM were similar in the two groups. Rate of mid-ventricular obstruction (MVO) was lower (2.9 vs. 14.3 %) in the type non-A group than in the type A group, though left ventricular ejection fractions in the two groups were comparable. During a follow-up period of 2.6 ± 2.8 years, TCM recurred in 2.9 % of the patients and cardiac death occurred in 4.0 %. Cox proportional hazard analysis indicated that body mass index (hazard ratio [HR]: 0.75, 95 % confidence interval [CI] 0.54-0.99) and MVO (HR: 14.71, CI 1.87-304.66) were determinants of TCM recurrence and that advanced age (HR: 1.09, CI 1.02-1.17) and cardiogenic shock (HR: 4.27, CI 1.07-18.93) were significantly associated with cardiac death. In conclusion, approximately 20 % of TCM patients show non-apical left ventricular ballooning, and female sex and MVO are less frequent in this type than in apical ballooning type TCM. Low body mass index and MVO are risk factors of recurrence, and advanced age and cardiogenic shock are risk factors of cardiac death in TCM.

Entities:  

Keywords:  Midventricular obstruction; Prognosis; Recurrence; Takotsubo cardiomyopathy

Mesh:

Year:  2014        PMID: 25059855     DOI: 10.1007/s00380-014-0548-x

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  35 in total

1.  The clinical characteristics, laboratory parameters, electrocardiographic, and echocardiographic findings of reverse or inverted takotsubo cardiomyopathy: comparison with mid or apical variant.

Authors:  Bong Gun Song; Woo Jung Chun; Yong Hwan Park; Gu Hyun Kang; JuHyeon Oh; Sang-Chol Lee; Seung Woo Park; Jae K Oh
Journal:  Clin Cardiol       Date:  2011-10-26       Impact factor: 2.882

2.  Natural history of tako-tsubo cardiomyopathy.

Authors:  Guido Parodi; Benedetta Bellandi; Stefano Del Pace; Alessandro Barchielli; Linda Zampini; Silvia Velluzzi; Nazario Carrabba; Gian Franco Gensini; David Antoniucci
Journal:  Chest       Date:  2010-09-30       Impact factor: 9.410

3.  Reverse or inverted takotsubo cardiomyopathy (reverse left ventricular apical ballooning syndrome) presents at a younger age compared with the mid or apical variant and is always associated with triggering stress.

Authors:  Radhakrishnan Ramaraj; Mohammad Reza Movahed
Journal:  Congest Heart Fail       Date:  2010-10-29

4.  Apical ballooning without apical ballooning.

Authors:  Hendrik Bonnemeier; Ulrich Schäfer; Heribert Schunkert
Journal:  Eur Heart J       Date:  2006-02-23       Impact factor: 29.983

5.  Transient midventricular ballooning syndrome: a new variant.

Authors:  R Todd Hurst; J Wells Askew; Christina S Reuss; Richard W Lee; John P Sweeney; F David Fortuin; Jae K Oh; A Jamil Tajik
Journal:  J Am Coll Cardiol       Date:  2006-06-19       Impact factor: 24.094

6.  Reversible cardiomyopathy with pheochromocytoma.

Authors:  J G Wiswell; R M Crago
Journal:  Trans Am Clin Climatol Assoc       Date:  1969

7.  Catecholamine-induced cardiomyopathy in multiple endocrine neoplasia. A histologic, ultrastructural, and biochemical study.

Authors:  A Frustaci; F Loperfido; N Gentiloni; M Caldarulo; E Morgante; M A Russo
Journal:  Chest       Date:  1991-02       Impact factor: 9.410

8.  Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy.

Authors:  Scott W Sharkey; Denise C Windenburg; John R Lesser; Martin S Maron; Robert G Hauser; Jennifer N Lesser; Tammy S Haas; James S Hodges; Barry J Maron
Journal:  J Am Coll Cardiol       Date:  2010-01-26       Impact factor: 24.094

9.  Recurrent tako-tsubo-like left ventricular dysfunction (apical ballooning) in a patient with pheochromocytoma - a case report.

Authors:  C Spes; A Knape; H Mudra
Journal:  Clin Res Cardiol       Date:  2006-03-22       Impact factor: 5.460

10.  [Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases].

Authors:  K Dote; H Sato; H Tateishi; T Uchida; M Ishihara
Journal:  J Cardiol       Date:  1991       Impact factor: 3.159

View more
  9 in total

1.  Usefulness of contrast computed tomography to detect left ventricular apical thrombus associated with takotsubo cardiomyopathy.

Authors:  Kotaro Ouchi; Fumitaka Nakamura; Masayasu Ikutomi; Tsukasa Oshima; Jumpei Ishiwata; Hiroki Shinohara; Tsunashi Kouzaki; Toshihiro Amaki
Journal:  Heart Vessels       Date:  2015-01-29       Impact factor: 2.037

2.  Left ventricular mechanics in the acute phase of Takotsubo cardiomyopathy: distinctive ballooning patterns translate into different diastolic properties.

Authors:  Nathan Messas; Antonin Trimaille; Benjamin Marchandot; Kensuke Matsushita; Marion Kibler; Sébastien Hess; Guillaume Marquis-Gravel; E Marc Jolicoeur; Laurence Jesel; Patrick Ohlmann; Olivier Morel
Journal:  Heart Vessels       Date:  2019-09-27       Impact factor: 2.037

3.  Seasonal variation in patient characteristics and in-hospital outcomes of Takotsubo syndrome: a nationwide retrospective cohort study in Japan.

Authors:  Toshiaki Isogai; Hiroki Matsui; Hiroyuki Tanaka; Kiyohide Fushimi; Hideo Yasunaga
Journal:  Heart Vessels       Date:  2017-06-07       Impact factor: 2.037

4.  Antiplatelet therapy in Takotsubo cardiomyopathy: does it improve cardiovascular outcomes during index event?

Authors:  Andre Dias; Emiliana Franco; Nikoloz Koshkelashvili; Vikas Bhalla; Gregg S Pressman; Kathy Hebert; Vincent M Figueredo
Journal:  Heart Vessels       Date:  2015-08-13       Impact factor: 2.037

5.  Predictors of in-hospital cardiac complications in patients with Takotsubo syndrome.

Authors:  Ken Kato; Yoshiaki Sakai; Iwao Ishibashi; Toshiharu Himi; Yoshihide Fujimoto; Yoshio Kobayashi
Journal:  Heart Vessels       Date:  2018-04-25       Impact factor: 2.037

6.  Three Episodes of Takotsubo Cardiomyopathy with Variant Ballooning Patterns in 2 Elderly Women.

Authors:  Ravikiran Korabathina; Jamie Porcadas; Michael Mishkin; Angela Turner; Arthur J Labovitz
Journal:  Tex Heart Inst J       Date:  2018-08-01

Review 7.  Epidemiology and pathophysiology of Takotsubo syndrome.

Authors:  Yoshihiro J Akashi; Holger M Nef; Alexander R Lyon
Journal:  Nat Rev Cardiol       Date:  2015-04-07       Impact factor: 32.419

Review 8.  An Emerging Cardiovascular Disease: Takotsubo Syndrome.

Authors:  Sara Moscatelli; Fabrizio Montecucco; Federico Carbone; Alberto Valbusa; Laura Massobrio; Italo Porto; Claudio Brunelli; Gian Marco Rosa
Journal:  Biomed Res Int       Date:  2019-10-30       Impact factor: 3.411

9.  Factors Associated with Recurrence in Takotsubo Syndrome: A Systematic Review.

Authors:  Felipe Alverenga Duarte Campos; Luiz Eduardo Fonteles Ritt; João Paulo Soares Costa; Constança Margarida Cruz; Gilson Soares Feitosa-Filho; Queila Borges de Oliveira; Eduardo Sahade Darzé
Journal:  Arq Bras Cardiol       Date:  2020-03       Impact factor: 2.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.